AlzChem Group AG (ACT) — Cash Flow-to-Debt Ratio
AlzChem Group AG (ACT) has a Cash Flow-to-Debt Ratio of 0.03x as of June 2026, meaning its operating cash flow of €13.04 Million could theoretically repay 0% of its total liabilities (€402.19 Million) in one year. See ACT financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AlzChem Group AG Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for AlzChem Group AG across 14 annual periods. For the full cash flow conversion analysis, see AlzChem Group AG (ACT) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for AlzChem Group AG (2012–2025)
Year-by-year debt coverage analysis for AlzChem Group AG. Check AlzChem Group AG cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | €137.01 Million | €359.45 Million | ▲ +0.2% |
| 2024 | 0.38x | €105.15 Million | €276.36 Million | ▲ +36.7% |
| 2023 | 0.28x | €72.67 Million | €261.12 Million | ▲ +1917.6% |
| 2022 | -0.02x | €-4.24 Million | €276.91 Million | ▼ -110.3% |
| 2021 | 0.15x | €43.02 Million | €288.10 Million | ▼ -12.4% |
| 2020 | 0.17x | €48.71 Million | €285.64 Million | ▲ +9.9% |
| 2019 | 0.16x | €43.63 Million | €281.23 Million | ▲ +9.8% |
| 2018 | 0.14x | €34.66 Million | €245.16 Million | ▲ +2.5% |
| 2017 | 0.14x | €30.66 Million | €222.29 Million | ▲ +124.6% |
| 2016 | -0.56x | €-36.08K | €64.39K | ▲ +57.9% |
| 2015 | -1.33x | €-49.19K | €37.00K | ▼ -24033.1% |
| 2014 | 0.01x | €140.11 | €25.23K | ▼ -100.0% |
| 2013 | 1328.70x | €15.57 Million | €11.72K | ▼ -66.4% |
| 2012 | 3948.80x | €20.71 Million | €5.25K | — |